BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10403926)

  • 1. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal immune priming with helminth infections: parasite-specific cellular reactivity and Th1 and Th2 cytokine responses in neonates.
    Pit DS; Polderman AM; Schulz-Key H; Soboslay PT
    Allergy; 2000 Aug; 55(8):732-9. PubMed ID: 10955699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
    Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
    Soboslay PT; Dreweck CM; Hoffmann WH; Lüder CG; Heuschkel C; Görgen H; Banla M; Schulz-Key H
    Clin Exp Immunol; 1992 Sep; 89(3):407-13. PubMed ID: 1516257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and chemokine responses in adults, newborns and children exposed to Entamoeba histolytica/dispar, Onchocerca volvulus and Plasmodium falciparum.
    Kocherscheidt L; Agossou A; Gantin RG; Hamm DM; Banla M; Soboslay PT
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e756-63. PubMed ID: 20408971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.
    MacDonald AJ; Turaga PS; Harmon-Brown C; Tierney TJ; Bennett KE; McCarthy MC; Simonek SC; Enyong PA; Moukatte DW; Lustigman S
    Infect Immun; 2002 Jun; 70(6):2796-804. PubMed ID: 12010965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasite-specific antibody and cytokine profiles in newborns from Plasmodium falciparum and Entamoeba histolytica/dispar-infected mothers.
    Kirch AK; Agossou A; Banla M; Hoffmann WH; Schulz-Key H; Soboslay PT
    Pediatr Allergy Immunol; 2004 Apr; 15(2):133-41. PubMed ID: 15059189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune responses in human infection with Onchocerca volvulus.
    Gallin M; Edmonds K; Ellner JJ; Erttmann KD; White AT; Newland HS; Taylor HR; Greene BM
    J Immunol; 1988 Mar; 140(6):1999-2007. PubMed ID: 3257994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection.
    Soboslay PT; Dreweck CM; Taylor HR; Brotman B; Wenk P; Greene BM
    J Immunol; 1991 Jul; 147(1):346-53. PubMed ID: 2051025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up study.
    Kirch AK; Duerr HP; Boatin B; Alley WS; Hoffmann WH; Schulz-Key H; Soboslay PT
    Parasitology; 2003 Oct; 127(Pt 4):327-35. PubMed ID: 14636019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
    Sentongo E; Rubaale T; Büttner DW; Brattig NW
    Parasite Immunol; 1998 Sep; 20(9):431-9. PubMed ID: 9767610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
    Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
    Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice.
    Pearlman E; Lass JH; Bardenstein DS; Diaconu E; Hazlett FE; Albright J; Higgins AW; Kazura JW
    Exp Parasitol; 1996 Nov; 84(2):274-81. PubMed ID: 8932777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.